Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update 2010 Jul-Aug;16(4):347-363.
Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril 2012 Jan;97(1):28-38.e25.
Revised 2003 consensus on diagnostic criteria and longterm health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004 Jan;19(1):41-47.
The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 2007 Jun;92(6):2017-2029.
Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev 2012 Dec;33(6):981-1030.
Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 2008 Oct;29(6):726-776.
Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis. Fertil Steril 2011 Mar 1;95(3):1073-1079.e1-e11.
Vitamin D in the aetiology and management of polycystic ovary syndrome. Clin Endocrinol (Oxf) 2012 Sep;77(3):343-350.
Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 1989 Sep;38(9):1165-1174.
Low levels of 25(OH)D and insulin-resistance: 2 unrelated features or a causeeffect in PCOS? Clin Nutr 2012 Aug;31(4):476-480.
Vitamin D supplementation has no effect on insulin resistance assessment in women with polycystic ovary syndrome and vitamin D deficiency. Nutr Res 2012 Mar;32(3):195-201.
Therapeutic effects of calcium & vitamin D supplementation in women with PCOS. Complement Ther Clin Pract 2012 May;18(2):85-88.
Therapeutic implications of vitamin D and calcium in overweight women with polycystic ovary syndrome. Gynecol Endocrinol 2012 Dec;28(12):965-968.
Effects of vitamin D on cardiovascular disease risk factors in polycystic ovary syndrome women with vitamin D deficiency. J Endocrinol Invest 2013 Jan;36(1):28-32.
The effects of calcium–vitamin D and metformin on polycystic ovary syndrome: a pilot study. Taiwan J Obstet Gynecol 2009 Jun;48(2):142-147.
Atorvastatin increases 25-hydroxy vitamin D concentrations in patients with polycystic ovary syndrome. Clin Chem 2010 Nov;56(11):1696-1700.
The effect of vitamin D replacement therapy on insulin resistance and androgen levels in women with polycystic ovary syndrome. J Endocrinol Invest 2010 Apr;33(4):234-238.
Vitamin D and calcium dysregulation in the polycystic ovarian syndrome. Steroids 1999 Jun;64(6):430-435.
Effect of vitamin D3 treatment on glucose metabolism and menstrual frequency in polycystic ovary syndrome women: a pilot study. J Endocrinol Invest 2011 Nov;34(10):757-763.
The effects of calcitriol on improvement of insulin resistance, ovulation and comparison with metformin therapy in PCOS patients: a randomized placebo-controlled clinical trial. Iran J Reprod Med 2012 Sep;10(5):465-472.
Role of vitamin D treatment in glucose metabolism in polycystic ovary syndrome. Fertil Steril 2009 Sep;92(3):1053-1058.
Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes 2006 Nov;114(10):577-583.
Vitamin D deficiency is common and associated with metabolic risk factors in patients with polycystic ovary syndrome. Metabolism 2011 Oct;60(10):1475-1481.
Calciotropic hormones, insulin resistance, and the polycystic ovary syndrome. Fertil Steril 2010 Mar 1;93(4):1208-1214.
Determinants of insulin responsiveness in young women: impact of polycystic ovarian syndrome, nitric oxide, and vitamin D. Nitric Oxide 2011 Oct 30;25(3):326-330.
Serum parathyroid hormone concentrations are increased in women with polycystic ovary syndrome. Clin Chem 2005 Sep;51(9):1691-1697.
Serum 25-hydroxyvitamin D Levels, phosphoprotein enriched in diabetes gene product (PED/PEA-15) and leptin-to-adiponectin ratio in women with PCOS. Nutr Metab (Lond) 2011 Nov 23;8:84.
Serum 25-hydroxyvitamin D concentrations in obese and non-obese women with polycystic ovary syndrome. Arch Gynecol Obstet 2009 Oct;280(4):559-563.
Effect of 25-hydroxyvitamin D on metabolic parameters and insulin resistance in patients with polycystic ovarian syndrome. Middle East Fertil Soc J 2012 Sep;17(3):176-180.
Association between hypoadiponectinemia and low serum concentrations of calcium and vitamin D in women with polycystic ovary syndrome. ISRN Endocrinol 2012;2012:949427.
Vitamin D as a predictor of insulin resistance in polycystic ovarian syndrome. Diabetes Metab Syndr 2012 Jul-Sep;6(3):146-149.
Vitamin D receptor 1a promoter K1521 G/C and K1012 A/G polymorphisms in polycystic ovary syndrome. Taiwan J Obstet Gynecol 2012 Dec;51(4):565-571.
Influence of gene variants related to calcium homeostasis on biochemical parameters of women with polycystic ovary syndrome. J Assist Reprod Genet 2011 Mar;28(3):225-232.
Vitamin D-associated polymorphisms are related to insulin resistance and vitamin D deficiency in polycystic ovary syndrome. Eur J Endocrinol 2011 May;164(5):741-749.
PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis. Hum Reprod Update 2011 Jul-Aug;17(4):495-500.
Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 1999 Jan;22(1):141-146.
Polycystic ovary syndrome. Lancet 2007 Aug 25;370(9588):685-697.
Insulin-induced capillary recruitment is impaired in both lean and obese women with PCOS. Hum Reprod 2011 Nov;26(11):3130-3137.
Role of vitamin D in insulin secretion and insulin sensitivity for glucose homeostasis. Int J Endocrinol 2010;2010:351385.
Hypovitaminosis D is associated with insulin resistance and b cell dysfunction. Am J Clin Nutr 2004 May;79(5):820-825.
Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care 2005 May;28(5):1228-1230.
Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 2004 Dec;27(12):2813-2818.
Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome. Eur J Endocrinol 2009 Oct;161(4):575-582.
Genetic variation in the vitamin D receptor and polycystic ovary syndrome risk. Fertil Steril 2009 Oct;92(4):1381-1383.
A common variant in the adiponectin gene and polycystic ovary syndrome risk. Mol Biol Rep 2012 Mar;39(3):2313-2319.
Genetic polymorphism of vitamin D receptor gene affects the phenotype of PCOS. Gene 2013 Feb 15;515(1):193-196.
State-of-the-art vitamin D assays: a comparison of automated immunoassays with liquid chromatography–tandem mass spectrometry methods. Clin Chem 2012 Mar;58(3):531-542.
Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women. J Clin Endocrinol Metab 2005 Jul;90(7):4119-4123.
Rising serum 25-hydroxy-vitamin D levels after weight loss in obese women correlate with improvement in insulin resistance. J Clin Endocrinol Metab 2010 Sep;95(9):4251-4257.
The role of adipose cell size and adipose tissue insulin sensitivity in the carbohydrate intolerance of human obesity. J Clin Invest 1968 Jan;47(1):153-165.
b-Cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome. J Clin Endocrinol Metab 1996 Mar;81(3):942-947.
Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 1997 Dec;18(6):774-800.
Obese but not normal-weight women with polycystic ovary syndrome are characterized by metabolic and microvascular insulin resistance. J Clin Endocrinol Metab 2008 Sep;93(9):3365-3372.
The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care 2007 Apr;30(4):980-986.
Relation between serum 25-hydroxyvitamin D and C-reactive protein in asymptomatic adults (from the continuous National Health and Nutrition Examination Survey 2001 to 2006). Am J Cardiol 2012 Jan 15;109(2):226-230.
The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 2011 Jan;96(1):53-58.